AMA president blames insurers for surprise high medical bills; Pfizer continues to lead erectile dysfunction market after loss of Viagra exclusivity; Insys employees made ‘rap video’ encouraging fentanyl spray sales.
Congress invites drugmakers to testify about prices; CHC’s Bigelow wants pharma marketers to stick up for themselves; Microsoft develops service allowing Azure to connect healthcare professionals.
The deal makes MJH the largest privately held medical media company in the U.S.
Massachusetts officials say Purdue execs considered opioid addiction treatment an “attractive market”; FDA approves Mylan’s Advair generic; House Democrats want answers from drugmakers about insulin prices.
UnitedHealth sues former executive; The debut episode of The MM&M Podcast; Planned Parenthood develops sex ed chatbot.
Patients, medical groups launch campaign in opposition to Trump’s pricing proposal; Diabetes pill considered for FDA approval; The MM&M Podcast teaser.
Day three at JP Morgan Healthcare Conference; Sanders-Cummings drug-pricing bill introduced; First patient treated under Right to Try Law.
In the Make the Switch push, the company is using testimonials from people who say Juul e-cigarettes helped them quit smoking.
BMS to buy Celgene for $74b; MDC names executive committee; Takeda creates immuno-oncology cell therapy unit.
J&J continues to deny Reuters’ allegations; Lawmakers express asbestos concerns to EPA; And the winner of the inaugural MM&M Holiday Contest is…
